[Experiences with plasmapheresis in the treatment of vascular rejection following kidney transplantation].
In the first 6 weeks after kidney transplantation 15 patients suffering from vascular rejection were treated by 46 plasmapheres. In transplants with additional interstitial rejection the plasmapheresis was introduced after failure of ATG therapy. In 1 patient no histological confirmation was done. In 4 patients the plasmapheresis was successful and in 6 patients suffering from combined vascular and interstitial rejection the ATG therapy was successful only after initial plasmapheresis. In 4 cases the therapy failed to reverse rejection. The early use of plasmapheresis is recommended to obtain the best results.
Eismann
R
R
Urologische Universitätsklinik und Poliklinik, Martin-Luther-Universität Halle-Wittenberg.
Konert
J
J
Langkopf
B
B
D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001706:Biopsy; D003131:Combined Modality Therapy; D004730:Endothelium, Vascular / Q000473:pathology; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage; D010956:Plasmapheresis / Q000379:methods*; D012077:Renal Artery / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D008775:Methylprednisolone
Erfahrungen mit der Plasmapherese in der Behandlung der vaskulären Rejektion nach Nierentransplantation.